Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level

Table 8 Influence of different risk factors on multi-organ involvement in patients with post-transplant lymphoproliferative disorder

	Multi-organ involvement (+)	Multi-organ involvement (-)	P value
All PTLD patients
Sex			0.421
Male	12	19
Female	6	13
CMV status			0.418
CMV-positive	6	7
CMV-negative	7	5
EBV status			0.008
EBV-positive	5	11
EBV-negative	8	1
Rejection episode			0.448
(+)	9	14
(-)	9	18
Type of allograft			0.235
Living donor	8	19
Deceased donor	10	13
Pediatric PTL patients
Sex			0.206
Male	11	11
Female	5	11
CMV status			0.335
CMV-positive	5	7
CMV-negative	6	4
EBV status			0.006
EBV-positive	5	11
EBV-negative	6	0
Rejection episode			0.520
(+)	8	10
(-)	8	12
Type of allograft			0.019
Living donor	8	19
Deceased donor	8	3

CMV: Cytomegalovirus; EBV: Epstein-Barr virus; PTLD: Post-transplant lymphoproliferative disorder.